Correction: Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide

Oncogene 2026 Open access

Read full text

Authors: Junhong Li, zhe Hong, J. L. Zhang, Shengfeng Zheng, Fangning Wan, Zheng Liu, Bo Dai

DOI: 10.1038/s41388-026-03690-3

Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Epigenetics and DNA Methylation Cancer-related gene regulation